Issue 76 • July 2024

The rise of bioplastics in medical devices

How can the health equity gap be closed for wearable devices?

Briefing

BD to acquire Edwards Lifesciences’ Critical Care unit for $4.2bn

Feature

Vibrating gastric stimulators – the next big obesity treatment?

Fetature

Telehealth in the US: adapt or die?

Comment

Microbot Medical and Boston hospital collaborate on Liberty Surgical Robot trials

Thematic Take

IoT in Medical Devices

In association with

07/04/2024 11:02:43
  • Home | The rise of bioplastics in medical devices
  • Editor's letter
  • Contents
  • On Line Controls
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Project Updates
  • Trends & Insight
  • Alleima Company Insight
  • Alleima
  • In Depth
  • The rise of bioplastics in medical devices
  • Medtech’s digital supply chain revolution: innovations and challenges in 2024
  • Vibrating gastric stimulators – the next big obesity treatment?
  • Explainer: Why have there been so many job cuts in MedTech?
  • Telehealth in the US: adapt or die?
  • Transforming surgery: Microbot Medical and Boston hospital collaborate on Liberty Surgical Robot trials
  • Australia’s biggest week in Medtech in Adelaide
  • ASCO 2024 unveils practice-changing research in oncology, from new chemo regimens, to immunotherapy and beyond
  • Frankfurt Laser Company
  • Sponsored supplements
  • Listings
  • Events
  • Excellence Awards
  • Innovation Rankings
  • Buyer's Guides
  • Next issue
07/03/2024 00:00:00